(Q35593216)

9 August 2017

title

The efficacy of sirolimus in the treatment of patients with refractory uveitis (English)

1 reference

9 August 2017

1 reference

1 reference

V A Shanmuganathan

1

1 reference

9 August 2017

E M Casely

2

1 reference

9 August 2017

D Raj

3

1 reference

9 August 2017

R J Powell

4

1 reference

9 August 2017

A Joseph

5

1 reference

9 August 2017

W M Amoaku

6

1 reference

9 August 2017

H S Dua

7

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

9 August 2017

number of pages

4

1 reference

British Journal of Ophthalmology

inferred from page(s)

published in

1 reference

9 August 2017

volume

89

1 reference

9 August 2017

issue

6

1 reference

9 August 2017

page(s)

666-669

1 reference

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772655

The evolving role of sirolimus in renal transplantation

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772655

Molecular actions of sirolimus: sirolimus and mTor

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772655

Sirolimus therapy in cardiac transplantation

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772655

Sirolimus: a single center experience in combination with calcineurin inhibitors.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772655

Campath-1H therapy in refractory ocular inflammatory disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772655

Systemic corticosteroid therapy--side effects and their management

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772655

Tacrolimus-rapamycin combination therapy for experimental autoimmune uveoretinitis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772655

Causes and frequency of blindness in patients with intraocular inflammatory disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772655

Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772655

Long-term efficacy of mycophenolate mofetil in the control of severe intraocular inflammation

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772655

Infliximab in the treatment of refractory posterior uveitis

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772655

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772655

Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury. Its effect on cellular, growth factor, and cytokine response in injured vessels

26 September 2018

1 reference

12 December 2020

Rapamycin inhibits corneal allograft rejection and neovascularization

1 reference

12 December 2020

Synergistic effect of rapamycin and cyclosporin A in the treatment of experimental autoimmune uveoretinitis

1 reference

12 December 2020

Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation

1 reference

12 December 2020

Treatment of ocular inflammatory disorders with daclizumab

1 reference

12 December 2020

Inhibition of human B lymphocyte cell cycle progression and differentiation by rapamycin

1 reference

12 December 2020

Identifiers

DOI

10.1136/BJO.2004.048199

1 reference

9 August 2017

1 reference

9 August 2017

1 reference